Bibliografia
Zhu X, Smith MA, Honda K et al. Vascular oxidative stress in Alzheimer’s disease. J Neurol Sci 2007;257:240-246.
Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as risk factor for dementia and Alzheimer’s disease. NEJM 2002;346:476- 483.
Ravaglia G, Forti P, Maioli F et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82:636-643.
Babiloni, C, Bosco P, Ghidoni R et al. Homocysteine and electroencelographyc ritms in Alzheimer disease. 2007;143:942-954.
Engström I, Ronquist G, Petterson L, Waldenström A. Alzheimer amyloid beta-peptides exibit ionophore-like properties in human erithrocytes. Eur J Clin Invest 1995;25:471-476.
Sas K, Robotka H, Toldi J, Vécsei L. Mitochondria, metabolic disturbances, oxidative stress and kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007;257:221-239.
Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;433:787-795.
Mohanty JG, Eckley DM, JD Williamson et al. Do red blood cell-bamyloid interaction alter oxygen delivery in Alzheimer’s disease? Adv Exp Med Biol 2008;614:29-35.
Singer SJ, Dewji NN. Evidence that Perutz’s double-β-stranded subunit structure for β-amyloid also applies to their channel-forming structures in membranes. PNAS 2006;103:1546-1550.
Ravaglia G et al. Plasma tocopherol and risk of cognitive impairment in an elderly Italian cohort. Am J Clin Nutr 2008;87:1306-1313.
Dunn JE et al. Serum α-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment. Neurology 2007;68:670-676.
Mecocci P, Polidori MC, Cherubini A et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002;59:794-798.
Ravi LB, Mohanty JG Chrest FJ et al. Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells. Neurol Res 2004;26:579-585.
Lichtenstein AH, Russell RM. Essential Nutrients: food or supplements? Where should the emphasis be? JAMA 2005;294:351-358.
Cornelli U. Treatment of Alzheimer’s disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener Dis 2010;7:193-202
|